SAILIFE.NS Profit & Loss

Sai Life Sciences Ltd.

Profit & Loss · 2 years on file (FY2024-25 to FY2025-26) · fetched 2026-08-23 23:46

Line item	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹16.95 Bn	₹21.92 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹0.37 Bn	₹0.49 Bn	OtherIncome
Total Income	₹17.31 Bn	₹22.42 Bn	Income
Cost of Materials Consumed	₹4.61 Bn	₹5.78 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹0.00 Bn	₹0.00 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹0.05 Bn	₹-0.07 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹5.49 Bn	₹6.83 Bn	EmployeeBenefitExpense
Finance Costs	₹0.76 Bn	₹0.39 Bn	FinanceCosts
Depreciation and Amortisation	₹1.39 Bn	₹1.67 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹2.74 Bn	₹3.07 Bn	OtherExpenses
Total Expenses	₹15.04 Bn	₹17.67 Bn	Expenses
Profit Before Exceptional Items and Tax	₹2.28 Bn	₹4.74 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹0.00 Bn	₹-0.08 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹2.28 Bn	₹4.66 Bn	ProfitBeforeTax
Tax Expense	₹0.58 Bn	₹1.17 Bn	TaxExpense
Net Profit (incl. minority interest)	₹1.70 Bn	₹3.49 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	N/A	N/A	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹8.83	₹16.63	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹8.61	₹16.43	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from SAILIFE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).